Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Boundless Bio, Inc. Director's Dealing 2025

Feb 4, 2025

34838_dirs_2025-02-03_08a7eae3-00e1-49ae-a3ed-baee6cdde158.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Boundless Bio, Inc. (BOLD)
CIK: 0001782303
Period of Report: 2025-02-03

Reporting Person: Doebele Robert (N/A)

More from Boundless Bio, Inc.

Interim / Quarterly Report 2026
May 8
Report Publication Announcement 2026
May 8
Regulatory Filings 2026
Apr 13
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 5
Director's Dealing 2026
Jan 26
Director's Dealing 2026
Jan 26
Director's Dealing 2026
Jan 26
Director's Dealing 2026
Jan 26
Director's Dealing 2026
Jan 26
View all filings →